Hypertensive Urgency

Hypertensive urgency is defined as severely elevated blood pressure (SBP >180 and/or DBP >110–120 mm Hg) without evidence of new or worsening target-organ damage. [1-2] The 2024 AHA Scientific Statement recommends moving away from the term "hypertensive urgency" in favor of "asymptomatic markedly elevated BP" to avoid emotive language that may encourage unnecessary aggressive treatment. [2] The critical clinical task is distinguishing this from hypertensive emergency, which requires IV therapy and ICU admission. [1][3]

The following figure from the 2017 ACC/AHA guidelines illustrates the decision algorithm for managing hypertensive crises:

• Medication adherence: Nonadherence to prescribed antihypertensives is the most common precipitating factor — more than half of patients presenting with SBP ≥180 have already been prescribed ≥2 agents [3]
• Duration and chronicity of hypertension; baseline BP readings if available
• Timing of onset: sudden vs. gradual; any identifiable trigger (pain, anxiety, urinary retention, dietary indiscretion)
• Substance use: cocaine, amphetamines, sympathomimetics, NSAIDs, oral contraceptives, decongestants, high-dose glucocorticoids [3][5]
• Dietary sodium intake and recent changes
• Symptoms to characterize: headache, dizziness, epistaxis, anxiety — these are common but do NOT indicate end-organ damage [3]
• Important negatives: chest pain, dyspnea, focal neurologic deficits, visual changes, altered mental status, back/flank pain

The BARKH mnemonic (Brain, Arteries, Retina, Kidney, Heart) helps identify target-organ damage: [2]

• Brain: encephalopathy (confusion, seizures, cortical blindness), focal neurologic deficits (stroke), severe headache with altered sensorium
• Arteries: tearing chest/back pain (aortic dissection), pulse differential between extremities
• Retina: papilledema, flame hemorrhages, cotton-wool spots
• Kidney: oliguria, hematuria, acute rise in creatinine
• Heart: acute pulmonary edema (dyspnea, orthopnea, crackles), chest pain with ischemic features (ACS)
• Any of these findings reclassifies the patient as hypertensive emergency requiring IV therapy and ICU admission [1][3]

Medications that can elevate BP: [3][5]

• NSAIDs (ibuprofen, naproxen, COX-2 inhibitors)
• Sympathomimetics/decongestants (pseudoephedrine)
• Oral contraceptives/estrogen
• Glucocorticoids
• Stimulants (amphetamines, methylphenidate)
• Illicit drugs (cocaine, methamphetamine)
• MAOIs (tyramine interaction)
• Erythropoietin, calcineurin inhibitors, VEGF inhibitors
• Tricyclic antidepressants, clozapine

Acute oral treatment options (if symptoms present but no end-organ damage): [3]

Contraindicated/avoid

• Sublingual nifedipine: unpredictable, excessive BP reduction with risk of cardiovascular events [3]
• IV hydralazine for urgency: unpredictable response, 18% risk of >80 mmHg SBP drop [3][6]
• IV medications in general are discouraged for hypertensive urgency [1][3]

Key pearl: Rapid-acting antihypertensives (oral clonidine, IV hydralazine, IV labetalol) produce excessive SBP reduction (>80 mmHg) in ~18–20% of patients and MAP reduction >25% in 38–46%, exceeding cerebral autoregulatory limits. [6] Long-acting oral agents (e.g., lisinopril, extended-release nifedipine) carry significantly lower risk of overshoot. [6]

• Sodium: Dietary sodium indiscretion is a common precipitant of acute severe hypertension [3]
• Counsel on DASH diet principles and sodium restriction (<2,300 mg/day, ideally <1,500 mg/day)
• Adequate hydration — volume depletion can worsen BP lability
• Avoid licorice (mineralocorticoid effect), excessive caffeine, and tyramine-rich foods if on MAOIs

• Neuro: headache, visual changes, confusion, focal weakness/numbness, seizures
• Cardiac: chest pain, dyspnea, orthopnea, PND, palpitations, leg edema
• Vascular: tearing chest/back pain, claudication
• Renal: decreased urine output, hematuria, foamy urine
• Endocrine: episodic headache/sweating/palpitations (pheochromocytoma triad), weight gain, fatigue
• Psych: anxiety, panic symptoms
• ENT: epistaxis (common but not an end-organ damage marker)

• Confirm medication list and adherence from pharmacy records, family, or caregivers
• Family history of hypertension, early-onset CVD, stroke, renal disease
• Family history of pheochromocytoma/paraganglioma syndromes (MEN2, VHL, NF1) [7]
• Social context: access to medications, insurance status, health literacy — uninsured/underinsured patients are overrepresented [3]

• Age >60 years [3]
• Black race (higher prevalence and severity) [3]
• Medication nonadherence — the single strongest predictor [3]
• Uninsured/underinsured status, lower-income areas [3]
• Obesity, sedentary lifestyle, insulin resistance [1]
• High sodium intake, low potassium intake [1]
• Obstructive sleep apnea [7]
• CKD, diabetes mellitus
• Alcohol overuse [1]
• Illicit drug use (cocaine, amphetamines) [3]

Cannot-miss diagnoses (i.e., hypertensive emergency masquerading as urgency):

• Acute aortic dissection — tearing pain, pulse differential, widened mediastinum
• Acute stroke (ischemic or hemorrhagic) — focal deficits, altered consciousness
• Hypertensive encephalopathy — confusion, seizures, papilledema
• Acute coronary syndrome — chest pain, ECG changes, troponin elevation
• Acute pulmonary edema/HF — dyspnea, crackles, B-lines on POCUS
• Eclampsia/preeclampsia — in pregnant or postpartum patients
• Pheochromocytoma crisis — paroxysmal HTN with headache, sweating, palpitations [1-2]

Mimics of hypertensive urgency

• Pain-driven hypertension (treat the pain)
• Anxiety/panic attack
• Medication withdrawal (clonidine, beta-blockers)
• White-coat effect
• Bladder distension/urinary retention
• Acute kidney injury from other causes

• Prior hypertension diagnosis, duration, and baseline BP
• Previous hypertensive crises or ED visits for elevated BP
• History of CVD (MI, stroke, HF, PAD)
• CKD, diabetes, dyslipidemia
• Prior evaluation for secondary hypertension
• Surgical history (prior renal artery intervention, adrenalectomy, cardiac surgery)
• Pregnancy history (preeclampsia)

Vital signs: Repeat BP in both arms using proper technique (seated, rested 5 min, correct cuff size); check for orthostasis [2]

Focused exam

• Fundoscopy: papilledema, hemorrhages, exudates (if present → emergency) [2]
• Neuro: mental status, cranial nerves, motor/sensory, gait — any focal deficit → emergency
• Cardiac: S3/S4 gallop, murmurs, JVD
• Lungs: crackles (pulmonary edema)
• Vascular: bilateral arm BPs, femoral pulses (coarctation), carotid/abdominal bruits (renovascular disease)
• Abdomen: renal bruits, pulsatile mass

Expected findings in urgency: Elevated BP with otherwise normal exam. BP often decreases with 30 minutes of quiet rest — in one study, ~1/3 of patients fell below 180/110 before any medication. [3]

Recommended baseline workup: [2]

• BMP (creatinine, BUN, electrolytes — assess for AKI, hypokalemia suggesting hyperaldosteronism)
• CBC (microangiopathic hemolytic anemia in malignant HTN)
• Urinalysis (proteinuria, hematuria, casts)
• Troponin if chest pain or dyspnea present

Expected in urgency: Normal or at-baseline labs. Any acute abnormality (rising creatinine, elevated troponin, schistocytes) reclassifies as emergency.

Monitoring: Recheck creatinine and electrolytes at follow-up visit

• Chest X-ray: Assess for cardiomegaly, pulmonary edema, widened mediastinum [2]
• CT angiography: Only if aortic dissection suspected (tearing pain, pulse differential)
• CT head: Only if neurologic symptoms present
• Renal ultrasound/Doppler: Consider outpatient if secondary hypertension suspected (renal artery stenosis, CKD)
• Imaging is generally unnecessary in asymptomatic hypertensive urgency without alarm features

• Point-of-care ultrasound (POCUS): Cardiac (LV function, pericardial effusion), lung (B-lines for pulmonary edema), IVC (volume status) — rapid bedside assessment to rule out emergency
• Fundoscopic exam: Critical for identifying malignant hypertension (papilledema, flame hemorrhages)
• Urine drug screen: If sympathomimetic use suspected
• Outpatient secondary HTN workup (if indicated): aldosterone/renin ratio, plasma/urine metanephrines, TSH, renal artery duplex, sleep study [1][7]

• Indications: Obtain in all patients with markedly elevated BP presenting to the ED [2]
• Expected findings: May show LVH (chronic hypertension), which is not acute end-organ damage
• Concerning patterns: ST-segment changes (ischemia/infarction), new T-wave inversions, arrhythmias, strain pattern with acute symptoms
• Normal ECG supports the diagnosis of urgency over emergency

Clinical summary: Hypertensive urgency is a common, low-acuity presentation that is 2–3× more common than hypertensive emergency. [3] It is not associated with adverse short-term outcomes and can be managed in the ambulatory setting. [3]

Severity stratification

• Asymptomatic with SBP >180 → quiet rest, reassess, reinstitute/intensify oral meds
• Symptomatic (headache, epistaxis, anxiety) without end-organ damage → oral antihypertensive, observe, discharge with follow-up
• Any evidence of end-organ damage → reclassify as emergency

Complications to consider: While short-term risk is low, episodes of severe hypertension carry long-term cardiovascular implications and signal the need for improved chronic BP management. [3]

Initial management

• Quiet rest for 30 minutes with repeat BP — resolves ~1/3 of cases [3]
• Address precipitants: pain, anxiety, urinary retention, medication nonadherence
• Reinstitute or intensify oral antihypertensive medications — this is the guideline-recommended approach [1][3]

If symptomatic (headache, epistaxis) without end-organ damage:

• Oral captopril 25–50 mg, or oral labetalol 200–400 mg, or oral clonidine 0.1–0.2 mg [3]
• May repeat every 30 minutes until symptoms improve
• Prefer long-acting agents (lisinopril, amlodipine, extended-release nifedipine) to minimize overshoot risk [6]

What NOT to do

• Do not give IV antihypertensives for urgency [1]
• Do not use sublingual nifedipine [3]
• Do not target normalization of BP acutely — goal is symptom improvement and gradual reduction over days to weeks [1]
• Observational data show that initiation of as-needed IV or oral antihypertensives in hospitalized patients with asymptomatic severe HTN is associated with increased risk of AKI, in-hospital mortality, and prolonged stay [1]

Discharge criteria (most patients)

• No evidence of target-organ damage on history, exam, and basic workup
• Symptoms improved (if present)
• BP trending down or stable (does not need to be "normal" — discharge is reasonable once below ~160–180/100–110 mm Hg) [3]
• Oral antihypertensive regimen prescribed or adjusted
• Follow-up arranged within 1–7 days [3]

Admission criteria

• Any evidence of new/worsening target-organ damage (→ hypertensive emergency)
• Inability to exclude end-organ damage
• Persistent symptoms despite treatment
• Unreliable follow-up or medication access

Specialist consultation triggers

• Suspected secondary hypertension (young patient, resistant HTN, hypokalemia)
• Suspected pheochromocytoma or renovascular disease
• Refractory BP despite multi-drug regimen

Follow-up timing: Within 1–7 days with PCP or hypertension specialist [3]

Return precautions — instruct patients to return immediately for:

• Severe headache with confusion or vision changes
• Chest pain or shortness of breath
• Weakness or numbness on one side of the body
• Difficulty speaking
• Severe back or abdominal pain

Patient counseling

• Emphasize medication adherence as the single most important intervention [3]
• Discuss sodium restriction, weight management, alcohol moderation
• Home BP monitoring with a validated device
• Expected recovery: BP should be gradually controlled over days to weeks, not hours

Long-term considerations: Patients without a clear precipitant or with treatment-resistant hypertension should be evaluated for secondary causes (primary aldosteronism, renovascular disease, pheochromocytoma, OSA). [1][7]

1. 2025 AHA/­ACC/­AANP/­AAPA/­ABC/­ACCP/­ACPM/­AGS/­AMA/­ASPC/­NMA/­PCNA/­SGIM Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/­American Heart Association Joint Committee on Clinical Practice Guidelines. — Jones DW, Ferdinand KC, Taler SJ, et al. Journal of the American College of Cardiology. 2025.

2. The Management of Elevated Blood Pressure in the Acute Care Setting: A Scientific Statement From the American Heart Association. — Bress AP, Anderson TS, Flack JM, et al. Hypertension. 2024.

3. Acute Severe Hypertension. — Peixoto AJ. The New England Journal of Medicine. 2019.

4. 2017 ACC/­AHA/­AAPA/­ABC/­ACPM/­AGS/­APhA/­ASH/­ASPC/­NMA/­PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/­American Heart Association Task Force on Clinical Practice Guidelines. — Whelton PK, Carey RM, Aronow WS, et al. Journal of the American College of Cardiology. 2018.

5. Arterial Hypertension. — Brouwers S, Sudano I, Kokubo Y, Sulaica EM. Lancet. 2021.

6. Acute Blood Pressure Reduction Exceeding Safety and Autoregulatory Limits Following Rapid-Acting Antihypertensives for Hypertensive Urgency. — Preston RA, Caizapanta EV, Afshartous D, et al. Journal of Hypertension. 2026.

7. Diagnosis and Management of Resistant Hypertension. — Azizi M, Vongpatanasin W, Fisher NDL, et al. The Journal of the American Medical Association. 2026.